Anti cancer and anti viral effect of TcR alpha beta depleted DLI Lessons learned from three children and utility for further indications

dc.contributor.authorKARAKÜKCÜ MUSA
dc.contributor.authorÜnal, Ekrem
dc.contributor.authorMUTLU FATMA TÜRKAN
dc.contributor.authorYILMAZ EBRU
dc.contributor.authorIŞIK BİLGEN
dc.contributor.authorGÜL KIRKAŞ ÖZLEM
dc.contributor.authorPATIROĞLU TÜRKAN
dc.contributor.authorÖZDEMİR MEHMET AKİF
dc.date.accessioned2026-10-15T04:24:54Z
dc.date.issued2015
dc.descriptionUluslararası | Tam metin bildiri | YÖK-Özgeçmiş
dc.identifier.urihttps://hdl.handle.net/20.500.11782/13359
dc.relation.ispartof41st Annual Meeting of the European-Society-for-Blood-and-Marrow-TransplantationLocation: Istanbul, TURKEYDate: MAR 22-25, 2015
dc.titleAnti cancer and anti viral effect of TcR alpha beta depleted DLI Lessons learned from three children and utility for further indications
dc.typeConference Object
dspace.entity.typePublication
hku.portal.eseridt:bildiri:f951bb186044ddea
hku.yoksis.yayinid2421679
relation.isAuthorOfPublicationcd35ec05-b9b3-4f63-a13f-bc9dc6344971
relation.isAuthorOfPublication.latestForDiscoverycd35ec05-b9b3-4f63-a13f-bc9dc6344971

Dosyalar